Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)
Clinical trial NCT03783377 · COMPLETED
Trial details
- NCT number
- NCT03783377
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-08
- Primary completion
- 2021-02-11
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.